AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Stock Price Down 1.4% – Should You Sell?

Shares of AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) traded down 1.4% on Tuesday . The company traded as low as $11.91 and last traded at $11.91. 821,451 shares were traded during mid-day trading, a decline of 1% from the average session volume of 831,496 shares. The stock had previously closed at $12.08.

AGF U.S. Market Neutral Anti-Beta Fund Stock Performance

The firm’s 50 day simple moving average is $11.70 and its 200-day simple moving average is $12.75. The company has a market cap of $297.61 million, a price-to-earnings ratio of 17.67 and a beta of -0.64.

Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund

Several large investors have recently bought and sold shares of BTAL. CoreCap Advisors LLC purchased a new position in AGF U.S. Market Neutral Anti-Beta Fund in the 2nd quarter worth approximately $36,000. Triumph Capital Management purchased a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund in the third quarter valued at approximately $70,000. J.Safra Asset Management Corp grew its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 10.0% in the fourth quarter. J.Safra Asset Management Corp now owns 8,142 shares of the company’s stock valued at $117,000 after purchasing an additional 741 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock valued at $380,000 after purchasing an additional 10,146 shares during the last quarter. Finally, Worth Asset Management LLC increased its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.5% in the first quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock valued at $425,000 after purchasing an additional 5,190 shares during the last quarter.

About AGF U.S. Market Neutral Anti-Beta Fund

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.